Sa.68. Ins2 Expression from NOD Bone Marrow Derived Cells Does Not Prevent or Delay Diabetes Development in NOD-Ins2 Knockout Mice

MLA

Ainhoa Martin-Pagola, et al. “Sa.68. Ins2 Expression from NOD Bone Marrow Derived Cells Does Not Prevent or Delay Diabetes Development in NOD-Ins2 Knockout Mice.” Clinical Immunology, vol. 127, Jan. 2008, pp. S102–03. EBSCOhost, https://doi.org/10.1016/j.clim.2008.03.289.

APA

Ainhoa Martin-Pagola, R. D. Molano, Antonello Pileggi, Francesco Vendrame, Alberto Pugliese, E. Zahr, & Camillo Ricordi. (2008). Sa.68. Ins2 Expression from NOD Bone Marrow Derived Cells Does Not Prevent or Delay Diabetes Development in NOD-Ins2 Knockout Mice. Clinical Immunology, 127, S102–S103. https://doi.org/10.1016/j.clim.2008.03.289

Chicago

Ainhoa Martin-Pagola, R. D. Molano, Antonello Pileggi, Francesco Vendrame, Alberto Pugliese, E. Zahr, and Camillo Ricordi. 2008. “Sa.68. Ins2 Expression from NOD Bone Marrow Derived Cells Does Not Prevent or Delay Diabetes Development in NOD-Ins2 Knockout Mice.” Clinical Immunology 127 (January): S102–3. doi:10.1016/j.clim.2008.03.289.